Cumberland Pharmaceuticals Inc.: accounts_payable
| Value | {"amount": 11222333, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-03-31) |
| Status | current |
| Entity | Cumberland Pharmaceuticals Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:49:05.543728+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c3dab4cc-f18b-4bf6-b8a8-c40999ce245f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-23-017951Retrieved: 2026-08-19T10:49:05.543728+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001087294/accounts-payable/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c3dab4cc-f18b-4bf6-b8a8-c40999ce245f
History
- no predecessors — first report